David Elashoff

About David Elashoff

David Elashoff, With an exceptional h-index of 89 and a recent h-index of 56 (since 2020), a distinguished researcher at University of California, Los Angeles, specializes in the field of Biostatistics, Statistics, Biomarkers.

His recent articles reflect a diverse array of research interests and contributions to the field:

EPR24-116: Improving Anal Cancer Screening: A Comparative Analysis of High-Risk Human Papillomavirus Tests, Alone or in Combination With Anal Cytology Assays, to Predict High …

Distinctive profile of monomeric and polymeric anti-SSA/Ro52 immunoglobulin A1 isoforms in saliva of patients with primary Sjögren’s syndrome and Sicca

Early prediction of end-stage kidney disease using electronic health record data: a machine learning approach with a 2-year horizon

Optimizing an adaptive digital oral health intervention for promoting oral self-care behaviors: Micro-randomized trial protocol

Impact of delayed processing on cfDNA quantity and quality using STRECK cfDNA tubes: Connect Pilot Study

Twelve-Month Reach and Effectiveness of a University-Based Diabetes Prevention Initiative

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective …

Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients

David Elashoff Information

University

Position

Professor of Medicine Biostatistics and Computational Medicine

Citations(all)

37540

Citations(since 2020)

18711

Cited By

26734

hIndex(all)

89

hIndex(since 2020)

56

i10Index(all)

369

i10Index(since 2020)

307

Email

University Profile Page

Google Scholar

David Elashoff Skills & Research Interests

Biostatistics

Statistics

Biomarkers

Top articles of David Elashoff

EPR24-116: Improving Anal Cancer Screening: A Comparative Analysis of High-Risk Human Papillomavirus Tests, Alone or in Combination With Anal Cytology Assays, to Predict High …

Journal of the National Comprehensive Cancer Network

2024/4/5

Distinctive profile of monomeric and polymeric anti-SSA/Ro52 immunoglobulin A1 isoforms in saliva of patients with primary Sjögren’s syndrome and Sicca

RMD open

2024/4/1

Early prediction of end-stage kidney disease using electronic health record data: a machine learning approach with a 2-year horizon

JAMIA open

2024/4/1

Optimizing an adaptive digital oral health intervention for promoting oral self-care behaviors: Micro-randomized trial protocol

Contemporary Clinical Trials

2024/2/1

Impact of delayed processing on cfDNA quantity and quality using STRECK cfDNA tubes: Connect Pilot Study

Cancer Research

2024/3/22

Twelve-Month Reach and Effectiveness of a University-Based Diabetes Prevention Initiative

American Journal of Preventive Medicine

2024/2/1

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective …

European Urology Open Science

2022/10/1

744-P: Reach and Effectiveness of the University of California Diabetes Prevention Program Initiative

Diabetes

2023/6/20

Translated consent documents (CDs) and use in non-industry sponsored studies (NISS).

2023/6/1

Power doppler ultrasound signal predicts abnormal HDL function in patients with rheumatoid arthritis

Rheumatology International

2023/6

Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease

Scientific Reports

2023/5/27

David Elashoff
David Elashoff

H-Index: 51

Peter Chen
Peter Chen

H-Index: 2

HLA-B44 motif neoepitope is associated with a favorable tumor immune microenvironment and predicts ICB response in NSCLC

Cancer Research

2023/4/4

Peripheral Blood Cytokines Predict Primary Graft Dysfunction after Lung Transplantation

The Journal of Heart and Lung Transplantation

2023/4/1

Patient-reported outcomes before treatment for localized prostate cancer: are there differences among countries? Data from the True North Global Registry

BMC urology

2023/11/3

Improved outcomes in rheumatoid arthritis with obesity after a weight loss intervention: randomized trial

Rheumatology

2023/2/1

146 HLA-B44 motif neoepitope is associated with an anti-tumor immune microenvironment and predicts response to immune checkpoint blockade in non-small cell lung cancer

2023/11/1

Pregnancies complicated by gestational diabetes and fetal growth restriction: an analysis of maternal and fetal body composition using magnetic resonance imaging

Journal of Perinatology

2023/1

Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor–Intolerant Patients

Kidney International Reports

2023/1/1

David Elashoff
David Elashoff

H-Index: 51

Suphamai Bunnapradist
Suphamai Bunnapradist

H-Index: 37

Warning symptoms associated with imminent sudden cardiac arrest: a population-based case-control study with external validation

The Lancet Digital Health

2023/11/1

See List of Professors in David Elashoff University(University of California, Los Angeles)

Co-Authors

academic-engine